|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,282,637,741 |
|
|
Indirect Value
|
$6,840,070,897 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$9,122,708,638 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-19 |
4 |
B |
$1.39 |
$45,906 |
I/I |
33,000 |
10,777,709 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-07-03 |
4 |
B |
$4.15 |
$46,033 |
I/I |
11,100 |
5,092,500 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-03 |
4 |
B |
$1.95 |
$54,080 |
I/I |
27,739 |
13,412,692 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-05 |
4 |
B |
$1.98 |
$56,065 |
I/I |
28,283 |
13,537,275 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-16 |
4 |
B |
$3.12 |
$58,919 |
I/I |
18,900 |
4,506,432 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-07 |
4 |
B |
$0.58 |
$63,264 |
I/I |
109,700 |
8,129,099 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-08 |
4 |
B |
$0.62 |
$63,829 |
I/I |
103,100 |
5,000,999 |
1.5 |
- |
|
GYRE |
Gyre Therapeutics |
Direct Beneficial Owner |
|
2009-07-09 |
4 |
B |
$3.10 |
$66,646 |
D/D |
21,500 |
2,686,609 |
2.45 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-12 |
4 |
B |
$5.00 |
$74,000 |
I/I |
14,800 |
4,654,600 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2009-01-21 |
4 |
B |
$3.06 |
$77,097 |
I/I |
25,200 |
5,930,647 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2009-01-23 |
4 |
B |
$2.00 |
$79,456 |
I/I |
39,728 |
16,002,207 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-03-23 |
4 |
S |
$2.75 |
$79,750 |
D/D |
(29,000) |
5,845,547 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-11 |
4 |
B |
$0.60 |
$83,224 |
I/I |
139,100 |
8,282,199 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-03-26 |
4 |
S |
$2.70 |
$84,249 |
D/D |
(31,200) |
5,421,547 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-07-28 |
4 |
S |
$1.85 |
$90,665 |
D/D |
(49,000) |
6,019,557 |
0 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-30 |
4 |
B |
$2.94 |
$92,667 |
I/I |
31,500 |
6,213,551 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-26 |
4 |
B |
$5.00 |
$103,975 |
I/I |
20,800 |
3,890,100 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-05-28 |
4 |
B |
$4.72 |
$104,312 |
I/I |
22,100 |
5,054,800 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-05 |
4 |
B |
$0.60 |
$108,186 |
I/I |
180,400 |
8,008,199 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-07-02 |
4 |
B |
$4.18 |
$111,098 |
I/I |
26,600 |
5,081,400 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-01-14 |
4 |
B |
$4.50 |
$111,600 |
I/I |
24,800 |
5,955,577 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-18 |
4 |
B |
$1.38 |
$112,536 |
I/I |
81,400 |
10,744,709 |
1.5 |
- |
|
NTII |
Neurobiological Technolog... |
Indirect Beneficial Owner |
|
2007-11-06 |
4 |
B |
$2.43 |
$114,083 |
I/I |
47,000 |
4,938,393 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-28 |
4 |
B |
$5.00 |
$115,000 |
I/I |
23,000 |
3,913,100 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-04 |
4 |
B |
$4.97 |
$115,418 |
I/I |
23,200 |
4,081,700 |
1.5 |
- |
|
195 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|